These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 15073745)

  • 1. Definitions of terms for reporting adverse drug reactions (IX): nervous system and psychiatric disorders.
    Council for International Organizations of Medical Sciences
    Pharmacoepidemiol Drug Saf; 1998 Jan; 7(1):39-49. PubMed ID: 15073745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Definitions and basic requirements for the use of terms for reporting adverse drug reactions (XI): cardiovascular system disorders.
    Bankowski Z
    Pharmacoepidemiol Drug Saf; 1998 Sep; 7(5):351-7. PubMed ID: 15073983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Definitions and basic requirements for the use of terms for reporting adverse drug reactions (XII): collagen disorders and musculo-skeletal disorders.
    Council for International Organizations of Medical Sciences
    Pharmacoepidemiol Drug Saf; 1999 Mar; 8(2):141-5. PubMed ID: 15073939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Definitions and basic requirements for the use of terms for reporting adverse drug reactions (XIII): clinical pathology and general disorders.
    Council for International Organization of Medical Sciences
    Pharmacoepidemiol Drug Saf; 1999 May; 8(3):217-24. PubMed ID: 15073931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basic requirements for the use of terms for reporting adverse drug reactions (VIII): renal and urinary system disorders.
    Council for International Organizations of Medical Sciences
    Pharmacoepidemiol Drug Saf; 1997 May; 6(3):203-11. PubMed ID: 15073789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Definitions and basic requirements for the use of terms for reporting adverse drug reactions (X): gastrointestinal system disorders.
    Pharmacoepidemiol Drug Saf; 1998 Jul; 7(4):281-7. PubMed ID: 15073991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [International reporting of adverse drug reactions. Final report of CIOMS ADR Working Group].
    Royer RJ; Benichou C
    Therapie; 1991; 46(3):173-8. PubMed ID: 1792648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Standardization of definitions and criteria of causality assessment of adverse drug reactions. Drug-induced cytopenia.
    Int J Clin Pharmacol Ther Toxicol; 1991 Feb; 29(2):75-81. PubMed ID: 2026468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Standardization of definitions and criteria for causality assessment of adverse drug reactions. Drug-induced blood cytopenias: report of an international consensus meeting.
    Benichou C; Solal Celigny P
    Nouv Rev Fr Hematol (1978); 1991; 33(3):257-62. PubMed ID: 1956763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishing requirements for the use of terms for reporting adverse drug reactions (ADR). Consultant, Council for International Organizations of Medical Sciences (CIOMS), World Health Organization.
    Mater Med Pol; 1993; 25(1):45-6. PubMed ID: 8412342
    [No Abstract]   [Full Text] [Related]  

  • 11. Establishing requirements for the use of terms for reporting adverse drug reactions.
    Venulet J
    Int J Clin Pharmacol Res; 1992; 12(2):61-4. PubMed ID: 1428299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standardization of definitions and criteria of causality assessment of adverse drug reactions. Drug-induced liver disorders: report of an international consensus meeting.
    Int J Clin Pharmacol Ther Toxicol; 1990 Aug; 28(8):317-22. PubMed ID: 2272712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Criteria of drug-induced liver disorders. Report of an international consensus meeting.
    Bénichou C
    J Hepatol; 1990 Sep; 11(2):272-6. PubMed ID: 2254635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knowledge acquisition for computation of semantic distance between WHO-ART terms.
    Iavindrasana J; Bousquet C; Jaulent MC
    Stud Health Technol Inform; 2006; 124():839-44. PubMed ID: 17108617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Session of CIOMS (Council for International Organizations of Medical Sciences), Geneva, September 9-12, 1970].
    Horejsí J
    Cas Lek Cesk; 1970 Nov; 109(49):1153-4. PubMed ID: 5488975
    [No Abstract]   [Full Text] [Related]  

  • 16. Adverse drug reactions reporting at a referral hospital in Zimbabwe.
    Khoza S; Madungwe I; Nyambayo P; Mthethwa J; Chikuni O
    Cent Afr J Med; 2004; 50(11-12):104-7. PubMed ID: 16615658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reasons for reporting adverse drug reactions--some thoughts based on an international review.
    Biriell C; Edwards IR
    Pharmacoepidemiol Drug Saf; 1997 Jan; 6(1):21-6. PubMed ID: 15073801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paediatric adverse drug reaction reporting: understanding and future directions.
    Carleton BC; Smith MA; Gelin MN; Heathcote SC
    Can J Clin Pharmacol; 2007; 14(1):e45-57. PubMed ID: 17297195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping of the WHO-ART terminology on Snomed CT to improve grouping of related adverse drug reactions.
    Alecu I; Bousquet C; Mougin F; Jaulent MC
    Stud Health Technol Inform; 2006; 124():833-8. PubMed ID: 17108616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse event reporting and developments in radiation biology after normal tissue injury: International Atomic Energy Agency consultation.
    Chen Y; Trotti A; Coleman CN; Machtay M; Mirimanoff RO; Hay J; O'brien PC; El-Gueddari B; Salvajoli JV; Jeremic B
    Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1442-51. PubMed ID: 16414207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.